ATLASMEDX
AtlasMedx develops targeted small molecule drugs to improve the health of cancer patients. Its drugs are discovered and developed in the form of a small molecule that simultaneously targets compensatory DNA repair, cell division, and migration mechanisms that let doctors selectively kill cancer cells and overcome resistance to chemotherapy while protecting healthy cells to treat and conquer cancer. The company was founded in 2014 and is headquartered in San Francisco, California.
ATLASMEDX
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.atlasmedx.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Squarespace Hosted
Similar Organizations
Aviara Pharmaceuticals
Aviara Pharmaceuticals is the development of small molecule integrin inhibitors that modulate the activity.
Cahaba Pharmaceuticals
Cahaba Pharmaceuticals develops novel therapeutics and supportive care products for cancer patients.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spherics
Spherics develops proprietary bioadhesive encapsulation technologies to improve the oral absorption of small molecule drugs.
Current Employees Featured
Founder
Official Site Inspections
http://www.atlasmedx.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "AtlasMedx"
ABOUT US - Atlas Medx
AtlasMedx leadership team combines many years of comprehensive pharmaceutical, operational and commercialization experience. Our management team has: Extensive expertise in …See details»
AtlasMedx - Crunchbase Company Profile & Funding
AtlasMedx develops targeted small molecule drugs to improve the health of cancer patients. Its drugs are discovered and developed in the form of a small …See details»
ATLASMEDX, INC. Company Profile | San Francisco, CA
Find company research, competitor information, contact details & financial data for ATLASMEDX, INC. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
INVESTORS & MEDIA - Atlas Medx
Contact Us. AtlasMedx, Inc 2010 Crow Canyon Place Suite 100 San Ramon, CA 94583. [email protected]See details»
AtlasMedx - The Org
AtlasMedx develops targeted small molecule drugs to improve the health of cancer patients.See details»
AtlasMedx Inc - VentureRadar
AtlasMedx is advancing AMXI-5001, a first-in class orally bioavailable, small-molecule dual PARP and microtubule polymerization inhibitor. AtlasMedx aims to dramatically improve the …See details»
AtlasMedx's Board of Directors - Team members and org chart
The board of directors at AtlasMedx has a history of experience in the pharmaceutical industry, academia, and quality assurance. Many of the members have experience with large molecule …See details»
AtlasMedx - Headquarter Location, Corporate Office Address and …
AtlasMedx headquarter office and corporate office address is located in 1700 4th Street, QB3 Byers Hall 214, MC 2522 San Francisco, CA 94158 United States. Where is AtlasMedx …See details»
AtlasMedx 2025 Company Profile: Valuation, Funding & Investors
AtlasMedx General Information Description. Developer of targeted anti-cancer drugs designed to improve the health of cancer patients. The company's drugs are discovered and developed in …See details»
Organization | AtlasMedx, Inc
Organization Overview. First Clinical Trial. 2020 NCT04503265. First Marketed Drug. None First NDA Approval. None Last Known Activity ... AtlasMedx, Inc | AtlasMedx, Incorporated Active …See details»
CONTACT US — Atlas Medx
ATLASMEDX, INC 2010 Crow Canyon Place Suite 100 San Ramon, CA 94583. [email protected] AtlasMedx aims to dramatically improve the therapeutic outcome and …See details»
AtlasMedx - 2025 Company Profile & Competitors - Tracxn
Apr 4, 2025 AtlasMedx is an unfunded company based in San Francisco (United States), founded in 2016 by Hassan Alaoui. It operates as a Targeted small molecule therapeutics for …See details»
Atlasmedx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Atlasmedx, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease ...See details»
AtlasMedx - Products, Competitors, Financials, Employees, …
AtlasMedx is a clinical stage biopharmaceutical company focused on developing innovative cancer therapies. The company's main offerings include highly targeted therapeutics that …See details»
AtlasMedx - Overview, News & Similar companies | ZoomInfo.com
AtlasMedx aims to dramatically improve the therapeutic outcome and quality-of-life for cancer patients through the development and commercializatio n of transformational and highly …See details»
AtlasMedx Inc - VentureRadar
AtlasMedx aims to dramatically improve the therapeutic outcome and quality-of-life for cancer patients through the development and commercialization of transformational and highly …See details»
AtlasMedx，Inc:Company Profile & Technical Research,Competitor …
AtlasMedx，Inc is headquartered in United States California. AtlasMedx，Inc was founded in 2014. AtlasMedx，Inc has a total of 19 patents . Related Topics. Health care Pharmacy and …See details»
PIPELINE - Atlas Medx
AtlasMedx, Inc is focused on discovering and developing innovative and transformational small molecule drugs to treat and conquer cancer. TECHNOLOGY. AtlasMedx therapeutic strategy …See details»
Arc Institute Teams with 10x and Ultima Genomics to Evolve …
2 days ago “I don’t think people understand quite how complex a cell is, the scale that will be needed, and how incredibly impactful it will be when it’s solved,” Gilad Almogy, PhD, co …See details»
PARTNERING - Atlas Medx
AtlasMedx seeks appropriate enabling partnership opportunities to enhance and accelerate its unique approach to small molecule drug discovery and development. We are exceptionally …See details»